Academic articles on the clinical benefits of using FerriScan technique and LIC measurement.
Ho, P.J., et al., Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study. Hemasphere, 2019. 3(3): p. e224.
https://pubmed.ncbi.nlm.nih.gov/31723837
Taher, A., et al., Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. Blood, 2012. 120: p. 970-977.
https://pubmed.ncbi.nlm.nih.gov/22589472
Taher, A., et al., Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. Annals of Hematology, 2013: p. 1-9.
https://pubmed.ncbi.nlm.nih.gov/23775581
Brown, G.C., et al., Spin density projection-assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia. Internal Medicine Journal, 2012. 42(9): p. 990-996.